Related Experiment Video
Updated: Oct 15, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Evolving Concepts of Type 2 Diabetes Management.
Layla A Abushamat1, Jane E B Reusch2
1Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, MS 8106, 12801 East 17th Avenue, Room 7103, Aurora, CO 80045, USA.
This review covers current glucose-lowering diabetes medications, emphasizing patient-centered care. Shared decision-making should consider patient factors and new evidence for cardiorenal protection.
Area of Science:
- Endocrinology
- Pharmacology
- Patient-Centered Care
Background:
- Current diabetes medications offer various glucose-lowering mechanisms.
- Patient-centered care necessitates individualized treatment selection.
- Evolving evidence impacts antihyperglycemic agent recommendations.
Purpose of the Study:
- To outline available glucose-lowering diabetes medications.
- To highlight characteristics for shared decision-making in diabetes therapy.
- To integrate recent evidence on cardiorenal protection.
Main Methods:
- Review of current antihyperglycemic agents.
- Analysis of medication characteristics relevant to patient factors.
- Consideration of FDA guidance and recent clinical trial data.
Main Results:
- Multiple classes of glucose-lowering medications exist with distinct profiles.
- Patient-specific factors (weight, hypoglycemia risk, cost, social determinants, literacy) are crucial.
- Cardiovascular and cardiorenal benefits/risks guide modern agent selection.
Conclusions:
- Effective diabetes management requires shared decision-making tailored to individual patients.
- Antihyperglycemic agents should be chosen considering both glucose control and cardiorenal outcomes.
- A patient-centered approach, informed by updated evidence, ensures durable and effective diabetes therapy.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

